Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

61 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Harmonized Data Quality Indicators Maintain Data Quality in Long-Term Safety Studies Using Multiple Sclerosis Registries/Data Sources: Experience from the CLARION Study.
Hillert J, Butzkueven H, Magyari M, Wergeland S, Moore N, Soilu-Hänninen M, Ziemssen T, Kuhle J, Pontieri L, Forsberg L, Aarseth JH, Zhu C, Sicignano N, Mushnikov V, Bezemer I, Sabidó M. Hillert J, et al. Among authors: wergeland s. Clin Epidemiol. 2024 Oct 17;16:717-732. doi: 10.2147/CLEP.S480525. eCollection 2024. Clin Epidemiol. 2024. PMID: 39435029 Free PMC article.
The CLARION study: first report on safety findings in patients newly initiating treatment with cladribine tablets or fingolimod for multiple sclerosis.
Butzkueven H, Hillert J, Soilu-Hänninen M, Ziemssen T, Kuhle J, Wergeland S, Magyari M, Berger JR, Moore N, Aydemir A, Bezemer I, Sabidó M. Butzkueven H, et al. Among authors: wergeland s. Curr Med Res Opin. 2023 Oct;39(10):1367-1374. doi: 10.1080/03007995.2023.2256220. Epub 2023 Sep 7. Curr Med Res Opin. 2023. PMID: 37675878
BCG vaccination and multiple sclerosis risk: A Norwegian cohort study.
Nakken O, Aarseth JH, Wergeland S, Stigum H, Meyer HE, Holmøy T. Nakken O, et al. Among authors: wergeland s. Mult Scler. 2024 May;30(6):646-653. doi: 10.1177/13524585241230440. Epub 2024 Feb 27. Mult Scler. 2024. PMID: 38414125 Free PMC article.
The Norwegian Multiple Sclerosis Registry and Biobank.
Myhr KM, Grytten N, Torkildsen Ø, Wergeland S, Bø L, Aarseth JH. Myhr KM, et al. Among authors: wergeland s. Acta Neurol Scand. 2015;132(199):24-8. doi: 10.1111/ane.12427. Acta Neurol Scand. 2015. PMID: 26046555 Review.
Predictors of hospitalization due to infection in rituximab-treated MS patients.
Karlowicz JR, Klakegg M, Aarseth JH, Bø L, Myhr KM, Torgauten HM, Torkildsen Ø, Wergeland S. Karlowicz JR, et al. Among authors: wergeland s. Mult Scler Relat Disord. 2023 Mar;71:104556. doi: 10.1016/j.msard.2023.104556. Epub 2023 Feb 11. Mult Scler Relat Disord. 2023. PMID: 36842313 Free article.
Neurofilament light chain predicts disease activity in relapsing-remitting MS.
Varhaug KN, Barro C, Bjørnevik K, Myhr KM, Torkildsen Ø, Wergeland S, Bindoff LA, Kuhle J, Vedeler C. Varhaug KN, et al. Among authors: wergeland s. Neurol Neuroimmunol Neuroinflamm. 2017 Nov 28;5(1):e422. doi: 10.1212/NXI.0000000000000422. eCollection 2018 Jan. Neurol Neuroimmunol Neuroinflamm. 2017. PMID: 29209636 Free PMC article.
Perinatal Depression and Anxiety in Women With Multiple Sclerosis: A Population-Based Cohort Study.
Eid K, Torkildsen ØF, Aarseth J, Flemmen HØ, Holmøy T, Lorentzen ÅR, Myhr KM, Riise T, Simonsen C, Torkildsen CF, Wergeland S, Willumsen JS, Øksendal N, Gilhus NE, Bjørk MH. Eid K, et al. Among authors: wergeland s. Neurology. 2021 Jun 8;96(23):e2789-e2800. doi: 10.1212/WNL.0000000000012062. Epub 2021 Apr 21. Neurology. 2021. PMID: 33883236 Free PMC article.
61 results